Thomas R. Staab II
Overview
Thomas R. Staab II received an average of $1M in total compensation, including $392K in salary, at BioCryst Pharmaceuticals from 2011 to 2019.
2019BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2018BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2017BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2016BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2015BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2014BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2013BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2012BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
2011BioCryst PharmaceuticalsSenior Vice President and Chief Financial Officer
Source: SEC filings on March 31, 2020, April 17, 2019, May 10, 2018, April 12, 2017, April 11, 2016, April 10, 2015, and March 21, 2014.
Related executives
We found 16 more executives who work or worked at BioCryst Pharmaceuticals.
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
Yarlagadda Babu
BioCryst Pharmaceuticals
Chief Discovery Officer
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
Alane Barnes
BioCryst Pharmaceuticals